ArticleThe New England journal of medicine2014
Ponatinib in Philadelphia chromosome-positive leukemias.
Article in The New England journal of medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Trial
- The evolution of dasatinib dosage over the years and its relevance to other anticancer medications.Cancer · 2018Article
- Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives.Blood and lymphatic cancer : targets and therapy · 2018Review
- Best Practices in Chronic Myeloid Leukemia Monitoring and Management.The oncologist · 2016Review
- DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors.ACS chemical biology · 2015Article
- Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors.Biomarker insights · 2015Review
- Role of allogeneic hematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukemia.Mediterranean journal of hematology and infectious diseases · 2014Review
Corrections and comments
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24499221What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.